<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34695168</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease.</ArticleTitle><Pagination><StartPage>e1010018</StartPage><MedlinePgn>e1010018</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1010018</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1010018</ELocationID><Abstract><AbstractText>Parkinson's disease (PD) is one of the most common neurodegenerative diseases. PD is pathologically characterized by the death of midbrain dopaminergic neurons and the accumulation of intracellular protein inclusions called Lewy bodies or Lewy neurites. The major component of Lewy bodies is α-synuclein (α-syn). Prion-like propagation of α-syn has emerged as a novel mechanism in the progression of PD. This mechanism has been investigated to reveal factors that initiate Lewy pathology with the aim of preventing further progression of PD. Here, we demonstrate that coxsackievirus B3 (CVB3) infection can induce α-syn-associated inclusion body formation in neurons which might act as a trigger for PD. The inclusion bodies contained clustered organelles, including damaged mitochondria with α-syn fibrils. α-Syn overexpression accelerated inclusion body formation and induced more concentric inclusion bodies. In CVB3-infected mice brains, α-syn aggregates were observed in the cell body of midbrain neurons. Additionally, α-syn overexpression favored CVB3 replication and related cytotoxicity. α-Syn transgenic mice had a low survival rate, enhanced CVB3 replication, and exhibited neuronal cell death, including that of dopaminergic neurons in the substantia nigra. These results may be attributed to distinct autophagy-related pathways engaged by CVB3 and α-syn. This study elucidated the mechanism of Lewy body formation and the pathogenesis of PD associated with CVB3 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Soo Jin</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-6268-5231</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Convergence Research of Neurological Disorders, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Uram</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Convergence Research of Neurological Disorders, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sang Myun</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-1001-4743</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Convergence Research of Neurological Disorders, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016631" MajorTopicYN="N">Lewy Bodies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>25</Day><Hour>17</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34695168</ArticleId><ArticleId IdType="pmc">PMC8568191</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1010018</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-21-00344</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al.. Parkinson disease. Nature reviews Disease primers. 2017;3:17013. doi: 10.1038/nrdp.2017.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.13</ArticleId><ArticleId IdType="pubmed">28332488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912. Epub 2015/04/24. doi: 10.1016/S0140-6736(14)61393-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61393-3</ArticleId><ArticleId IdType="pubmed">25904081</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839–40. Epub 1997/08/28. doi: 10.1038/42166 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/42166</ArticleId><ArticleId IdType="pubmed">9278044</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbach J, Danzer KM. α-Synuclein in Parkinson’s disease: pathogenic function and translation into animal models. Neurodegenerative Diseases. 2014;14(1):1–17. doi: 10.1159/000354615</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000354615</ArticleId><ArticleId IdType="pubmed">24080741</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullin S, Schapira A. The genetics of Parkinson’s disease. British medical bulletin. 2015;114(1):39–52. doi: 10.1093/bmb/ldv022</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldv022</ArticleId><ArticleId IdType="pubmed">25995343</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al.. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nature genetics. 2014;46(9):989. doi: 10.1038/ng.3043</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3043</ArticleId><ArticleId IdType="pmc">PMC4146673</ArticleId><ArticleId IdType="pubmed">25064009</ArticleId></ArticleIdList></Reference><Reference><Citation>Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, et al.. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nature genetics. 2009;41(12):1303. doi: 10.1038/ng.485</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.485</ArticleId><ArticleId IdType="pubmed">19915576</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of aging. 2003;24(2):197–211. Epub 2002/12/25. doi: 10.1016/s0197-4580(02)00065-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-4580(02)00065-9</ArticleId><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Del Tredici K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology. 2008;70(20):1916–25. Epub 2008/05/14. doi: 10.1212/01.wnl.0000312279.49272.9f .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000312279.49272.9f</ArticleId><ArticleId IdType="pubmed">18474848</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpicelli-Daley L, Brundin P. Prion-like propagation of pathology in Parkinson disease. Handb Clin Neurol. 2018;153:321–35. Epub 2018/06/12. doi: 10.1016/B978-0-444-63945-5.00017-9 ; PubMed Central PMCID: PMC6625652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63945-5.00017-9</ArticleId><ArticleId IdType="pmc">PMC6625652</ArticleId><ArticleId IdType="pubmed">29887143</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas JY, Grudina C, Zurzolo C. The prion-like spreading of alpha-synuclein: From in vitro to in vivo models of Parkinson’s disease. Ageing Res Rev. 2019;50:89–101. Epub 2019/01/29. doi: 10.1016/j.arr.2019.01.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2019.01.012</ArticleId><ArticleId IdType="pubmed">30690184</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofaris GK, Goedert M, Spillantini MG. The Transcellular Propagation and Intracellular Trafficking of alpha-Synuclein. Cold Spring Harb Perspect Med. 2017;7(9). Epub 2016/12/07. doi: 10.1101/cshperspect.a024380 ; PubMed Central PMCID: PMC5580513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024380</ArticleId><ArticleId IdType="pmc">PMC5580513</ArticleId><ArticleId IdType="pubmed">27920026</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochimica et biophysica acta. 2009;1792(7):714–21. doi: 10.1016/j.bbadis.2008.08.001 ; PubMed Central PMCID: PMC4642437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2008.08.001</ArticleId><ArticleId IdType="pmc">PMC4642437</ArticleId><ArticleId IdType="pubmed">18760350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tulisiak CT, Mercado G, Peelaerts W, Brundin L, Brundin P. Can infections trigger alpha-synucleinopathies? Prog Mol Biol Transl Sci. 2019;168:299–322. Epub 2019/11/09. doi: 10.1016/bs.pmbts.2019.06.002 ; PubMed Central PMCID: PMC6857718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2019.06.002</ArticleId><ArticleId IdType="pmc">PMC6857718</ArticleId><ArticleId IdType="pubmed">31699323</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, et al.. Coxsackievirus B3 replication and pathogenesis. Future microbiology. 2015;10(4):629–53. doi: 10.2217/fmb.15.5</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam PE. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral immunology. 2006;19(2):133–46. doi: 10.1089/vim.2006.19.133</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.133</ArticleId><ArticleId IdType="pubmed">16817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P, Van Loon A. Enterovirus infections of the central nervous system. Intervirology. 1997;40(2–3):153–66. doi: 10.1159/000150542</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150542</ArticleId><ArticleId IdType="pubmed">9450232</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol. 2008;323:275–92. Epub 2008/03/25. doi: 10.1007/978-3-540-75546-3_13 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-75546-3_13</ArticleId><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou EK, Sané F, Engelmann I, Geenen V, Hober D. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discov Med. 2014;18(100):273–82. Epub 2014/11/27. .</Citation><ArticleIdList><ArticleId IdType="pubmed">25425468</ArticleId></ArticleIdList></Reference><Reference><Citation>Dourmashkin RR, McCall SA, Dourmashkin N, Hannah MJ. Virus-like particles and enterovirus antigen found in the brainstem neurons of Parkinson’s disease. F1000Research. 2018;7. doi: 10.12688/f1000research.13626.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.13626.2</ArticleId><ArticleId IdType="pmc">PMC5968367</ArticleId><ArticleId IdType="pubmed">29899977</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatman EL, Massey A, Shives KD, Burrack KS, Chamanian M, Morrison TE, et al.. Alpha-synuclein expression restricts RNA viral infections in the brain. Journal of virology. 2016;90(6):2767–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810656</ArticleId><ArticleId IdType="pubmed">26719256</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale M Jr., Tan SL, Katze MG. Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev. 2000;64(2):239–80. Epub 2000/06/06. doi: 10.1128/MMBR.64.2.239-280.2000 ; PubMed Central PMCID: PMC98994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.64.2.239-280.2000</ArticleId><ArticleId IdType="pmc">PMC98994</ArticleId><ArticleId IdType="pubmed">10839817</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhungel P, Cantu FM, Molina JA, Yang Z. Vaccinia Virus as a Master of Host Shutoff Induction: Targeting Processes of the Central Dogma and Beyond. Pathogens. 2020;9(5):400. doi: 10.3390/pathogens9050400</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9050400</ArticleId><ArticleId IdType="pmc">PMC7281567</ArticleId><ArticleId IdType="pubmed">32455727</ArticleId></ArticleIdList></Reference><Reference><Citation>Inglis S. Inhibition of host protein synthesis and degradation of cellular mRNAs during infection by influenza and herpes simplex virus. Molecular and Cellular Biology. 1982;2(12):1644. doi: 10.1128/mcb.2.12.1644-1648.1982</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.2.12.1644-1648.1982</ArticleId><ArticleId IdType="pmc">PMC369973</ArticleId><ArticleId IdType="pubmed">14582206</ArticleId></ArticleIdList></Reference><Reference><Citation>Schek N, Bachenheimer SL. Degradation of cellular mRNAs induced by a virion-associated factor during herpes simplex virus infection of Vero cells. Journal of Virology. 1985;55(3):601. doi: 10.1128/JVI.55.3.601-610.1985</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.55.3.601-610.1985</ArticleId><ArticleId IdType="pmc">PMC255019</ArticleId><ArticleId IdType="pubmed">4020960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Harris K, Wimmer E, Dasgupta A. Inhibition of basal transcription by poliovirus: a virus-encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. Journal of virology. 1996;70(5):2922. doi: 10.1128/JVI.70.5.2922-2929.1996</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.70.5.2922-2929.1996</ArticleId><ArticleId IdType="pmc">PMC190150</ArticleId><ArticleId IdType="pubmed">8627767</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 2001;413(6857):732. doi: 10.1038/35099560</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35099560</ArticleId><ArticleId IdType="pubmed">11607032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Alirezaei M, Flynn CT, Wood MR, Harkins S, Kiosses WB, et al.. Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo. Journal of virology. 2010;84(23):12110–24. doi: 10.1128/JVI.01417-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01417-10</ArticleId><ArticleId IdType="pmc">PMC2976412</ArticleId><ArticleId IdType="pubmed">20861268</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibutani ST, Saitoh T, Nowag H, Münz C, Yoshimori T. Autophagy and autophagy-related proteins in the immune system. Nature immunology. 2015;16(10):1014–24. doi: 10.1038/ni.3273</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3273</ArticleId><ArticleId IdType="pubmed">26382870</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Molecular neurobiology. 2013;47(2):495–508. doi: 10.1007/s12035-012-8280-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-012-8280-y</ArticleId><ArticleId IdType="pubmed">22622968</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, et al.. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nature Neuroscience. 2019;22(7):1099. doi: 10.1038/s41593-019-0423-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0423-2</ArticleId><ArticleId IdType="pubmed">31235907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J, Choi J, Joo CH, Seo I, Kim D, Yoon SY, et al.. Susceptibility of mouse primary cortical neuronal cells to coxsackievirus B. J Gen Virol. 2004;85(Pt 6):1555–64. Epub 2004/05/29. doi: 10.1099/vir.0.19695-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19695-0</ArticleId><ArticleId IdType="pubmed">15166439</ArticleId></ArticleIdList></Reference><Reference><Citation>Shults NV, Kanovka SS, Ten Eyck JE, Rybka V, Suzuki YJ. Ultrastructural changes of the right ventricular myocytes in pulmonary arterial hypertension. Journal of the American Heart Association. 2019;8(5):e011227. doi: 10.1161/JAHA.118.011227</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.011227</ArticleId><ArticleId IdType="pmc">PMC6474942</ArticleId><ArticleId IdType="pubmed">30807241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Zhang J, Si X, Gao G, Mao I, McManus BM, et al.. Autophagosome supports coxsackievirus B3 replication in host cells. Journal of virology. 2008;82(18):9143–53. doi: 10.1128/JVI.00641-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00641-08</ArticleId><ArticleId IdType="pmc">PMC2546883</ArticleId><ArticleId IdType="pubmed">18596087</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, et al.. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222. Epub 2016/01/23. doi: 10.1080/15548627.2015.1100356 ; PubMed Central PMCID: PMC4835977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1100356</ArticleId><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii SR, Mizushima N. Monitoring and Measuring Autophagy. Int J Mol Sci. 2017;18(9):1865. Epub 2017/08/29. doi: 10.3390/ijms18091865 ; PubMed Central PMCID: PMC5618514.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091865</ArticleId><ArticleId IdType="pmc">PMC5618514</ArticleId><ArticleId IdType="pubmed">28846632</ArticleId></ArticleIdList></Reference><Reference><Citation>Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L. Abberant α-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PloS one. 2009;4(5):e5515. doi: 10.1371/journal.pone.0005515</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005515</ArticleId><ArticleId IdType="pmc">PMC2677735</ArticleId><ArticleId IdType="pubmed">19436756</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuorinen T, Kallajoki M, Hyypiä T, Vainionpää R. Coxsackievirus B3-induced acute pancreatitis: analysis of histopathological and viral parameters in a mouse model. Br J Exp Pathol. 1989;70(4):395–403. Epub 1989/08/01. ; PubMed Central PMCID: PMC2040566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2040566</ArticleId><ArticleId IdType="pubmed">2548562</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall JH, Clemens DL. Use of Coxsackievirus B3 as a Model of Acute Pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base. 2016. doi: 10.3998/panc.2016.33</Citation><ArticleIdList><ArticleId IdType="doi">10.3998/panc.2016.33</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C, Schlossmacher MG. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology. 2007;69(22):2093–104. doi: 10.1212/01.wnl.0000271880.27321.a7</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000271880.27321.a7</ArticleId><ArticleId IdType="pubmed">17761553</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P. Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis. Trends Neurosci. 2019;42(1):4–13. Epub 2018/10/22. doi: 10.1016/j.tins.2018.09.007 ; PubMed Central PMCID: PMC6623978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.09.007</ArticleId><ArticleId IdType="pmc">PMC6623978</ArticleId><ArticleId IdType="pubmed">30342839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahul-Mellier AL, Burtscher J, Maharjan N, Weerens L, Croisier M, Kuttler F, et al.. The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(9):4971–82. Epub 2020/02/23. doi: 10.1073/pnas.1913904117 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1913904117</ArticleId><ArticleId IdType="pmc">PMC7060668</ArticleId><ArticleId IdType="pubmed">32075919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashuel HA. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports. Neurobiology of disease. 2020:104876. Epub 2020/04/28. doi: 10.1016/j.nbd.2020.104876 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104876</ArticleId><ArticleId IdType="pubmed">32339655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, et al.. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. 1998;96(5):445–52. Epub 1998/11/26. doi: 10.1007/s004010050918 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050918</ArticleId><ArticleId IdType="pubmed">9829807</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuse O, Iseki E, Marui W, Kosaka K. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci. 2003;211(1–2):29–35. Epub 2003/05/28. doi: 10.1016/s0022-510x(03)00037-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(03)00037-6</ArticleId><ArticleId IdType="pubmed">12767494</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008;283(14):9089–100. Epub 2008/02/05. doi: 10.1074/jbc.M710012200 ; PubMed Central PMCID: PMC2431021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M710012200</ArticleId><ArticleId IdType="pmc">PMC2431021</ArticleId><ArticleId IdType="pubmed">18245082</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, et al.. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem. 2011;286(23):20710–26. Epub 2011/04/15. doi: 10.1074/jbc.M110.213538 ; PubMed Central PMCID: PMC3121472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.213538</ArticleId><ArticleId IdType="pmc">PMC3121472</ArticleId><ArticleId IdType="pubmed">21489994</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Burgess JD, Faroqi AH, DeMeo NN, Fiesel FC, Springer W, et al.. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway. Mol Neurodegener. 2020;15(1):5. Epub 2020/01/15. doi: 10.1186/s13024-019-0349-x ; PubMed Central PMCID: PMC6956494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0349-x</ArticleId><ArticleId IdType="pmc">PMC6956494</ArticleId><ArticleId IdType="pubmed">31931835</ArticleId></ArticleIdList></Reference><Reference><Citation>Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, et al.. Induction of alpha-synuclein aggregation by intracellular nitrative insult. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2001;21(20):8053–61. Epub 2001/10/06. doi: 10.1523/jneurosci.21-20-08053.2001 ; PubMed Central PMCID: PMC6763872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.21-20-08053.2001</ArticleId><ArticleId IdType="pmc">PMC6763872</ArticleId><ArticleId IdType="pubmed">11588178</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. Journal of Biological Chemistry. 2008;283(35):23542–56. doi: 10.1074/jbc.M801992200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M801992200</ArticleId><ArticleId IdType="pmc">PMC2527094</ArticleId><ArticleId IdType="pubmed">18566453</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, et al.. Chaperone-mediated autophagy markers in Parkinson disease brains. Archives of neurology. 2010;67(12):1464–72. doi: 10.1001/archneurol.2010.198</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.198</ArticleId><ArticleId IdType="pubmed">20697033</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanis L, Emmanouilidou E, Pantazopoulou M, Kirik D, Vekrellis K, Tofaris GK. How is alpha-synuclein cleared from the cell? Journal of neurochemistry. 2019;150(5):577–90. Epub 2019/05/10. doi: 10.1111/jnc.14704 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14704</ArticleId><ArticleId IdType="pubmed">31069800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejlerskov P, Hultberg JG, Wang J, Carlsson R, Ambjorn M, Kuss M, et al.. Lack of Neuronal IFN-beta-IFNAR Causes Lewy Body- and Parkinson’s Disease-like Dementia. Cell. 2015;163(2):324–39. Epub 2015/10/10. doi: 10.1016/j.cell.2015.08.069 ; PubMed Central PMCID: PMC4601085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.08.069</ArticleId><ArticleId IdType="pmc">PMC4601085</ArticleId><ArticleId IdType="pubmed">26451483</ArticleId></ArticleIdList></Reference><Reference><Citation>Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE. Alpha-synuclein expression in substantia nigra and cortex in Parkinson’s disease. Mov Disord. 1999;14(3):417–22. Epub 1999/05/29. doi: 10.1002/1531-8257(199905)14:3&amp;lt;417::aid-mds1005&amp;gt;3.0.co;2-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8257(199905)14:3&amp;lt;417::aid-mds1005&amp;gt;3.0.co;2-x</ArticleId><ArticleId IdType="pubmed">10348463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ. Alteration in alpha-synuclein mRNA expression in Parkinson’s disease. Mov Disord. 2004;19(2):162–70. Epub 2004/02/24. doi: 10.1002/mds.10683 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.10683</ArticleId><ArticleId IdType="pubmed">14978671</ArticleId></ArticleIdList></Reference><Reference><Citation>Blyszczuk P. Myocarditis in Humans and in Experimental Animal Models. Front Cardiovasc Med. 2019;6:64. Epub 2019/06/04. doi: 10.3389/fcvm.2019.00064 ; PubMed Central PMCID: PMC6532015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2019.00064</ArticleId><ArticleId IdType="pmc">PMC6532015</ArticleId><ArticleId IdType="pubmed">31157241</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R, Ruller CM, An N, Tabor-Godwin JM, Rhoades RE, Maciejewski S, et al.. Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol. 2009;83(18):9356–69. Epub 2009/07/03. doi: 10.1128/JVI.02382-07 ; PubMed Central PMCID: PMC2738251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02382-07</ArticleId><ArticleId IdType="pmc">PMC2738251</ArticleId><ArticleId IdType="pubmed">19570873</ArticleId></ArticleIdList></Reference><Reference><Citation>Rantakallio P, Jones P, Moring J, Von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. International journal of epidemiology. 1997;26(4):837–43. doi: 10.1093/ije/26.4.837</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/26.4.837</ArticleId><ArticleId IdType="pubmed">9279617</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodall CJ, Graham DI. Evidence for neuronal localisation of enteroviral sequences in motor neurone disease/amyotrophic lateral sclerosis by in situ hybridization. Eur J Histochem. 2004;48(2):129–34. Epub 2004/06/23. doi: 10.4081/877 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/877</ArticleId><ArticleId IdType="pubmed">15208080</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Ruller CM, Fung G, Mohamud Y, Deng H, Liu H, et al.. Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo. Am J Pathol. 2018;188(12):2853–62. Epub 2018/10/03. doi: 10.1016/j.ajpath.2018.08.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2018.08.013</ArticleId><ArticleId IdType="pubmed">30273599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostin S, Pool L, Elsässer A, Hein S, Drexler HC, Arnon E, et al.. Myocytes die by multiple mechanisms in failing human hearts. Circulation research. 2003;92(7):715–24. doi: 10.1161/01.RES.0000067471.95890.5C</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000067471.95890.5C</ArticleId><ArticleId IdType="pubmed">12649263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanbe A, Osinska H, Saffitz JE, Glabe CG, Kayed R, Maloyan A, et al.. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proceedings of the National Academy of Sciences. 2004;101(27):10132–6. doi: 10.1073/pnas.0401900101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0401900101</ArticleId><ArticleId IdType="pmc">PMC454177</ArticleId><ArticleId IdType="pubmed">15220483</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermark GT, Krogvold L, Dahl-Jørgensen K, Ludvigsson J. Islet amyloid in recent-onset type 1 diabetes—the DiViD study. Upsala journal of medical sciences. 2017;122(3):201–3. doi: 10.1080/03009734.2017.1359219</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009734.2017.1359219</ArticleId><ArticleId IdType="pmc">PMC5649327</ArticleId><ArticleId IdType="pubmed">28814132</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen WC, Chiu HH, Chow KC, Tsai CH. MR imaging findings of enteroviral encephaloymelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol. 1999;20(10):1889–95. Epub 1999/12/10. .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657785</ArticleId><ArticleId IdType="pubmed">10588115</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson WT, Giddings TH Jr, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, et al.. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS biology. 2005;3(5):e156. doi: 10.1371/journal.pbio.0030156</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0030156</ArticleId><ArticleId IdType="pmc">PMC1084330</ArticleId><ArticleId IdType="pubmed">15884975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nature Reviews Microbiology. 2004;2(4):301. doi: 10.1038/nrmicro865</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro865</ArticleId><ArticleId IdType="pmc">PMC7097095</ArticleId><ArticleId IdType="pubmed">15031729</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon SY, Ha YE, Choi JE, Ahn J, Lee H, Kweon HS, et al.. Coxsackievirus B4 uses autophagy for replication after calpain activation in rat primary neurons. J Virol. 2008;82(23):11976–8. Epub 2008/09/19. doi: 10.1128/JVI.01028-08 ; PubMed Central PMCID: PMC2583648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01028-08</ArticleId><ArticleId IdType="pmc">PMC2583648</ArticleId><ArticleId IdType="pubmed">18799585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Olsen AL, Sygnecka K, Lohr KM, Feany MB. α-synuclein impairs autophagosome maturation through abnormal actin stabilization. PLoS Genet. 2021;17(2):e1009359. Epub 2021/02/09. doi: 10.1371/journal.pgen.1009359 ; PubMed Central PMCID: PMC7895402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1009359</ArticleId><ArticleId IdType="pmc">PMC7895402</ArticleId><ArticleId IdType="pubmed">33556113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S, Orba Y, Yamaguchi H, Takahashi K, Sasaki M, Hasebe R, et al.. Autophagy inhibits viral genome replication and gene expression stages in West Nile virus infection. Virus research. 2014;191:83–91. doi: 10.1016/j.virusres.2014.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.07.016</ArticleId><ArticleId IdType="pubmed">25091564</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, et al.. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494(7436):201. doi: 10.1038/nature11866</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11866</ArticleId><ArticleId IdType="pmc">PMC3788641</ArticleId><ArticleId IdType="pubmed">23364696</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H, Boltz D, McClaren J, Pani AK, Smeyne M, Korff A, et al.. Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. Journal of Neuroscience. 2012;32(5):1545–59. doi: 10.1523/JNEUROSCI.5123-11.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5123-11.2012</ArticleId><ArticleId IdType="pmc">PMC3307392</ArticleId><ArticleId IdType="pubmed">22302798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadasivan S, Zanin M, O’Brien K, Schultz-Cherry S, Smeyne RJ. Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus. PloS one. 2015;10(4). doi: 10.1371/journal.pone.0124047</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124047</ArticleId><ArticleId IdType="pmc">PMC4393251</ArticleId><ArticleId IdType="pubmed">25861024</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, Webster R, et al.. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proceedings of the National Academy of Sciences. 2009;106(33):14063–8. doi: 10.1073/pnas.0900096106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900096106</ArticleId><ArticleId IdType="pmc">PMC2729020</ArticleId><ArticleId IdType="pubmed">19667183</ArticleId></ArticleIdList></Reference><Reference><Citation>Marreiros R, Müller-Schiffmann A, Trossbach SV, Prikulis I, Hänsch S, Weidtkamp-Peters S, et al.. Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation. Proceedings of the National Academy of Sciences. 2020;117(12):6741–51. doi: 10.1073/pnas.1906466117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1906466117</ArticleId><ArticleId IdType="pmc">PMC7104400</ArticleId><ArticleId IdType="pubmed">32152117</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YR, Cha SH, Kang SJ, Kim JB, Jou I, Park SM. Prion-like Propagation of alpha-Synuclein Is Regulated by the FcgammaRIIB-SHP-1/2 Signaling Pathway in Neurons. Cell Rep. 2018;22(1):136–48. Epub 2018/01/04. doi: 10.1016/j.celrep.2017.12.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.12.009</ArticleId><ArticleId IdType="pubmed">29298416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nature methods. 2014;11(8):783. doi: 10.1038/nmeth.3047</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3047</ArticleId><ArticleId IdType="pmc">PMC4486245</ArticleId><ArticleId IdType="pubmed">25075903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopacinski AB, Sweatt AJ, Smolko CM, Gray-Gaillard E, Borgman CA, Shah M, et al.. Modeling the complete kinetics of coxsackievirus B3 reveals human determinants of host-cell feedback. Cell systems. 2021;12(4):304–23. e13. doi: 10.1016/j.cels.2021.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2021.02.004</ArticleId><ArticleId IdType="pmc">PMC8112228</ArticleId><ArticleId IdType="pubmed">33740397</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S, Park S, Han J, Kang J, Kim J, Lee J, et al.. Caspase-dependent cell death-associated release of nucleosome and damage-associated molecular patterns. Cell death &amp; disease. 2014;5(10):e1494–e. doi: 10.1038/cddis.2014.450</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.450</ArticleId><ArticleId IdType="pmc">PMC4649531</ArticleId><ArticleId IdType="pubmed">25356863</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson SM, Tsueng G, Sin J, Mangale V, Rahawi S, McIntyre LL, et al.. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS pathogens. 2014;10(4):e1004045. doi: 10.1371/journal.ppat.1004045</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004045</ArticleId><ArticleId IdType="pmc">PMC3983045</ArticleId><ArticleId IdType="pubmed">24722773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>